Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 3, 2008, Pages 783-789

  Lorenzo, Carlos ^a   Nath, Subrata D ^a   Hanley, Anthony J G ^b   Abboud, Hanna E ^a   Haffner, Steven M ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INSULIN; LEPTIN;

ADULT; AGED; ALBUMINURIA; ARTICLE; BLOOD; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; UNITED STATES;

ADULT; AGED; ALBUMINURIA; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FASTING; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; LEPTIN; METABOLIC SYNDROME X; MIDDLE AGED; SOUTHWESTERN UNITED STATES;

EID: 44649185754     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02730707     Document Type: Article

References (48)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003
2. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH: Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16: 180-188, 2005
3. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 16: 489-495, 2005
4. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA 291: 844-850, 2004
5. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, Gaziano JM: Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46: 871-880, 2005
6. Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D: Glycemic status and development of kidney disease: The Framingham Heart Study. Diabetes Care 28: 2436-2440, 2005
7. Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarød K, Holmen J: Obesity, smoking, and physical inactivity as risk factors for CKD: Are men more vulnerable? Am J Kidney Dis 47: 396-405, 2006
8. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174, 2004
9. Peralta CA, Kurella M, Lo JC, Chertow GM: The metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 15: 361-365, 2006
10. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139: 137-147, 2003
11. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM: Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 58: 1703-1710, 2000
12. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM: Microalbuminuria is associated with insulin resistance in nondiabetic subjects: The insulin resistance atherosclerosis study. Diabetes 47: 793-800, 1998
13. Meigs JB, D'Agostino RB Sr, Nathan DM, Rifai N, Wilson PW: Longitudinal association of glycemia and microalbuminuria: The Framingham Offspring Study. Diabetes Care 25: 977-983, 2002
14. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S: HOPE Study Investigators: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286: 421-426, 2001
15. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Jensen JS: Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110: 32-35, 2004
16. Kramer HJ, Nguyen QD, Curhan G, Hsu CY: Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 289: 3273-3277, 2003
17. MacIsaac RJ, Panagiotopoulos S, McNeil KJ, Smith TJ, Tsalamandris C, Hao H, Matthews PG, Thomas MC, Power DA, Jerums G: Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease? Diabetes Care 29: 1560-1566, 2006
18. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM: Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. Kidney Int 61: 2165-2175, 2002
19. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil KJ, Jerums G: Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 27: 195-200, 2004
20. Wagenknecht LE, Mayer EJ, Rewers M, Haffner S, Selby J, Borok GM, Henkin L, Howard G, Savage PJ, Saad MF, Bergman RN, Hamman R: The Insulin Resistance Atherosclerosis Study (IRAS): Objectives, design and recruitment results. Ann Epidemiol 5: 464-472, 1995
21. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocr Rev 6: 45-86, 1985
22. Kroll MH, Chesler R, Hagengruber C, Blank DW, Kestner J, Rawe M: Automated determination of urinary creatinine without sample dilution: theory and practice. Clin Chem 32: 446-452, 1986
23. Herbert V, Lau K, Gottlieb C, Bleicher S: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25: 1375-1384, 1965
24. Festa A, D'Agostino R Jr, Mykkanen L, Tracy RP, Zaccaro DJ, Hales CN, Haffner SM: Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol 19: 562-568, 1999
25. Macy E, Hayes T, Tracy R: Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference interval and epidemiological applications. Clin Chem 43:52-58, 1997
26. Festa A, D'Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM: Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 53: 1549-1555, 2004
27. Pacini G, Bergman RN: MINMOD: A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23: 113-122, 1986
28. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YD, Sands RE, Pei D, Savage PJ, Bergman RN: A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 43: 1114-1121, 1994
29. Korytkowski MT, Berga SL, Horwitz MJ: Comparison of the minimal model and the hyperglycemic clamp for measuring insulin sensitivity and acute insulin response to glucose. Metabolism 44: 1121-1125, 1995
30. Galling W, Knight C, Mullee MA, Hill RD: Microalbuminuria in diabetes: A population study of the prevalence and an assessment of three screening tests. Diabet Med 5: 343-347, 1988
31. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005
32. Ter Maaten JC, Bakker SJ, Serne EH, ter Wee PM, Donker AJ, Gans RO: Insulin's acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin's acute effects on proximal tubular sodium reabsorption correlation with salt sensitivity in normal subjects. Nephrol Dial Transplant 14: 2357-2363, 1999
33. Coward RJ, Welsh GI, Yang J, Tasman C, Lennon R, Koziell A, Satchell S, Holman GD, Kerjaschki D, Tavaré JM, Mathieson PW, Saleem MA: The human glomerular podocyte is a novel target for insulin action. Diabetes 54: 3095-3102, 2005
34. Abrass CK, Spicer D, Raugi GJ: Insulin induces a change in extracellular matrix glycoproteins synthesized by rat mesangial cells in culture. Kidney Int 46: 613-620, 1994
35. Mariappan MM, Feliers D, Mummidi S, Choudhury GG, Kasinath BS: High glucose, high insulin, and their combination rapidly induce laminin-betal synthesis by regulation of mRNA translation in renal epithelial cells. Diabetes 56: 476-485, 2007
36. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J: Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14: 469-477, 2003
37. Duckworth WC, Bennett RG, Hamel FG: Insulin degradation: Progress and potential. Endocr Rev 19: 608-624, 1998
38. Rosernbaun M, Leibel RL: The role of leptin in human physiology: N Engl J Med 341: 913-915, 1999
39. Heimburger O, Lonnqvist F, Danielsson A, Nordenstrom J, Stenvinkel P: Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 8: 1423-1430, 1997
40. Nordfors L, Lonnqvist F, Heimburger O, Danielsson A, Schalling M, Stenvinkel P: Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int 54: 1267-1275, 1998
41. Henegar J, Bigler S, Henegar L, Tuagi S, Hall J: Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12: 1211-1217, 2001
42. Wolf G, Hamann A, Han D, Helmchen U, Thaiss F, Ziyadeh FN, Stahl RA: Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: Potential role in glomerulosclerosis. Kidney Int 56: 860-872, 1999
43. Han DC, Isono M, Chen S, Casaretto A, Hong SW, Wolf G, Ziyadeh FN: Leptin stimulates type I collagen production in db/db mesangial cells: Glucose uptake and TGF-beta type II receptor expression. Kidney Int 59: 1315-1323, 2001
44. Sarnak MJ, Poindexter A, Wang SR, Beck GJ, Kusek JW, Marcovina SM, Greene T, Levey AS: Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 62: 2208-2215, 2002
45. Nelson RG, Tan M, Beck GJ, Bennett PH, Knowler WC, Mitch WE, Blouch K, Myers BD: Changing glomerular filtration with progression from impaired glucose tolerance to type II diabetes mellitus. Diabetologia 42: 90-93, 1999
46. Clase CM, Garg AX, Kiberd BA: Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 13: 1338-1349, 2002
47. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY: Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 32: 992-999, 1998
48. Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A: Estimation of renal function in subjects with normal serum creatinine levels: Influence of age and body mass index. Am J Kidney Dis 46: 233-241, 2005